PCV32 COST-EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION, TYPE-2 DIABETES AND RENAL DAMAGE IN MEXICO
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65447-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65447-2/fulltext
Section Title :
Section Order :
606
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65447-2&doi=10.1016/S1098-3015(10)65447-2